ConductScience.org, home

Paper393891

Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review.

Maack T and 4 others. Kidney Int, 1979. Cited by 783 papers, by iCite.

Cite this record

ConductScience Library. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Papers, record 393891. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/393891

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review.
PubMed
Journal
Kidney Int
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
783
iCite
Relative citation ratio, by iCite
23.7
iCite
Revised in PubMed
2019-07-25
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Maack TT
2Johnson VV
3Kau STS T
4Figueiredo JJ
5Sigulem DD

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood ProteinsMajor topic
KidneyMajor topic
Animals
Biological Transport
Dogs
Fishes
Glomerular Filtration Rate
Gonadotropins
Humans
In Vitro Techniques
Kidney Glomerulus
Kidney Tubules
Mice
Proteins
Proteinuria
Rabbits
Rats

Source PubMed

Download CSV of topics

Cited by170

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 783 citations.

PMIDTitleJournalYearIn PapersSource
42983320Disease states associated with lysozymuria, along with histological correlations.BMC Nephrol2026https://conductscience.org/library/papers/42983320PubMed
42699873A chimeric, half-life extended lysin with a unique mode of action.Front Microbiol2026https://conductscience.org/library/papers/42699873PubMed
42653122Beneficial Hepatokines in MASLD/MASH: Therapeutic Potentials and Drug Delivery Challenges.Int J Mol Sci2026https://conductscience.org/library/papers/42653122PubMed
42511953Renal Functional Reserve-Informed Personalized Renoprotection in Chronic Kidney Disease: A Proposed Extension of the KDIGO CGA Framework.Biomedicines2026https://conductscience.org/library/papers/42511953PubMed
41942053Therapeutic peptides and proteins: Status and developments in drug delivery.J Control Release2026https://conductscience.org/library/papers/41942053PubMed
41803103Heterogeneity in lysosomal dynamics and metabolic functions along the kidney proximal tubule.Nat Commun2026https://conductscience.org/library/papers/41803103PubMed
40868160Uncommon Factors Leading to Nephrotic Syndrome.Biomedicines2025https://conductscience.org/library/papers/40868160PubMed
39898971Phage-derived proteins: Advancing food safety through biocontrol and detection of foodborne pathogens.Compr Rev Food Sci Food Saf2025https://conductscience.org/library/papers/39898971PubMed
39762367Protein handling in kidney tubules.Nat Rev Nephrol2025https://conductscience.org/library/papers/39762367PubMed
39610876Obstacles, research progress, and prospects of oral delivery of bioactive peptides: a comprehensive review.Front Nutr2024https://conductscience.org/library/papers/39610876PubMed
38184374Unveiling cytokine charge disparity as a potential mechanism for immune regulation.Cytokine Growth Factor Rev2024https://conductscience.org/library/papers/38184374PubMed
38161981The negative impact of levothyroxine treatment on urinary luteinizing hormone measurements in pediatric patients with thyroid disease.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/38161981PubMed
37999893Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.BioDrugs2024https://conductscience.org/library/papers/37999893PubMed
37885887Kappa free light chains index in multiple sclerosis very long-term prognosis.Front Immunol2023https://conductscience.org/library/papers/37885887PubMed
37354999Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies.Biotechnol Adv2023https://conductscience.org/library/papers/37354999PubMed
36979933Urinary ACE Phenotyping as a Research and Diagnostic Tool: Identification of Sex-Dependent ACE Immunoreactivity.Biomedicines2023https://conductscience.org/library/papers/36979933PubMed
36826285Advanced Drug Delivery Systems for Renal Disorders.Gels2023https://conductscience.org/library/papers/36826285PubMed
36387592Advances in the stability challenges of bioactive peptides and improvement strategies.Curr Res Food Sci2022https://conductscience.org/library/papers/36387592PubMed
36175561Spatiotemporal organisation of protein processing in the kidney.Nat Commun2022https://conductscience.org/library/papers/36175561PubMed
36142600Molecular Biosimilarity-An AI-Driven Paradigm Shift.Int J Mol Sci2022https://conductscience.org/library/papers/36142600PubMed

See all 170 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/393891

GET https://conductscience.org/api/papers/v1/393891/cited_by?page=2